Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Protara Therapeutics, Inc. TARA
$3.38
+$0.01 (0.30%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
35054800.00000000
-
week52high
4.60
-
week52low
2.38
-
Revenue
0
-
P/E TTM
-1
-
Beta
1.54272000
-
EPS
-5.48000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 12:30
Описание компании
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 10 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 09 мая 2022 г. |
| Oppenheimer | Outperform | Outperform | 08 ноя 2021 г. |
| HC Wainwright & Co. | Buy | 04 июн 2021 г. | |
| Guggenheim | Buy | 25 ноя 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fabbio Patrick | A | 300000 | 300000 | 30 янв 2023 г. |
| Bandari Jathin | A | 124400 | 124400 | 19 янв 2023 г. |
| Bandari Jathin | A | 39142 | 20700 | 19 янв 2023 г. |
| Fry Hannah | A | 35400 | 35400 | 19 янв 2023 г. |
| Fry Hannah | A | 33139 | 5900 | 19 янв 2023 г. |
| Shefferman Jesse | A | 307500 | 307500 | 19 янв 2023 г. |
| Shefferman Jesse | A | 918282 | 51300 | 19 янв 2023 г. |
| Zummo Jacqueline | A | 119300 | 119300 | 19 янв 2023 г. |
| Zummo Jacqueline | A | 91473 | 19900 | 19 янв 2023 г. |
| Bandari Jathin | D | 18442 | 1876 | 10 янв 2023 г. |
Новостная лента
Protara Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
GlobeNewsWire
02 февр 2023 г. в 08:00
NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks Oncology Day on Thursday, February 9, 2023 at 11:20 am ET in New York, New York.
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
InvestorPlace
05 окт 2022 г. в 11:00
In October 2021, I made a big call on Longeveron (NASDAQ: LGVN ) stock, a biotech firm working on a promising Alzheimer's therapy.
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
Benzinga
16 авг 2022 г. в 07:14
The Dow Jones jumped by around 150 points on Monday. Investors, meanwhile, focused on some notable insider trades.